Literature DB >> 32436348

A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.

Melody T Tan1, Jean G Wu2, Juan Luis Callejas-Valera3, Richard A Schwarz1, Ann M Gillenwater4, Rebecca R Richards-Kortum1, Nadarajah Vigneswaran2.   

Abstract

Oral cancer causes significant global mortality and has a five-year survival rate of around 64%. Poor prognosis results from late-stage diagnosis, highlighting an important need to develop better approaches to detect oral premalignant lesions (OPLs) and identify which OPLs are at highest risk of progression to oral squamous cell carcinoma (OSCC). An appropriate animal model that reflects the genetic, histologic, immunologic, molecular and gross visual features of human OSCC would aid in the development and evaluation of early detection and risk assessment strategies. Here, we present an experimental PIK3CA + 4NQO transgenic mouse model of oral carcinogenesis that combines the PIK3CA oncogene mutation with oral exposure to the chemical carcinogen 4NQO, an alternate experimental transgenic mouse model with PIK3CA as well as E6 and E7 mutations, and an existing wild-type mouse model based on oral exposure to 4NQO alone. We compare changes in dorsal and ventral tongue gross visual appearance, histologic features and molecular biomarker expression over a time course of carcinogenesis. Both transgenic models exhibit cytological and architectural features of dysplasia that mimic human disease and exhibit slightly increased staining for Ki-67, a cell proliferation marker. The PIK3CA + 4NQO model additionally exhibits consistent lymphocytic infiltration, presents with prominent dorsal and ventral tongue tumours, and develops cancer quickly relative to the other models. Thus, the PIK3CA + 4NQO model recapitulates the multistep genetic model of human oral carcinogenesis and host immune response in carcinogen-induced tongue cancer, making it a useful resource for future OSCC studies.
© 2020 The Authors. International Journal of Experimental Pathology © 2020 International Journal of Experimental Pathology.

Entities:  

Keywords:  4NQO; PIK3CA; carcinogenesis; oral premalignant lesions; oral squamous cell carcinoma; transgenic mouse model

Mesh:

Substances:

Year:  2020        PMID: 32436348      PMCID: PMC7306900          DOI: 10.1111/iep.12347

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  34 in total

1.  Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study.

Authors:  L Montebugnoli; G Badiali; C Marchetti; F Cervellati; A Farnedi; M P Foschini
Journal:  Int J Oral Maxillofac Surg       Date:  2009-07-16       Impact factor: 2.789

Review 2.  Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.

Authors:  Yu Lei; Yuying Xie; Yee Sun Tan; Mark E Prince; Jeffrey S Moyer; Jacques Nör; Gregory T Wolf
Journal:  Oral Oncol       Date:  2016-08-21       Impact factor: 5.337

3.  Predictive value of high Ki-67 expression in stage I oral squamous cell carcinoma specimens after primary surgery.

Authors:  Christian Freudlsperger; Sandra E Rohleder; Siegmar Reinert; Juergen Hoffmann
Journal:  Head Neck       Date:  2010-08-04       Impact factor: 3.147

Review 4.  Epidemiologic trends in head and neck cancer and aids in diagnosis.

Authors:  Nadarajah Vigneswaran; Michelle D Williams
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-05       Impact factor: 2.802

Review 5.  Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.

Authors:  Kalen R Dionne; Saman Warnakulasuriya; Rosnah Binti Zain; Sok Ching Cheong
Journal:  Int J Cancer       Date:  2014-02-11       Impact factor: 7.396

6.  Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.

Authors:  Nishant Agrawal; Mitchell J Frederick; Curtis R Pickering; Chetan Bettegowda; Kyle Chang; Ryan J Li; Carole Fakhry; Tong-Xin Xie; Jiexin Zhang; Jing Wang; Nianxiang Zhang; Adel K El-Naggar; Samar A Jasser; John N Weinstein; Lisa Treviño; Jennifer A Drummond; Donna M Muzny; Yuanqing Wu; Laura D Wood; Ralph H Hruban; William H Westra; Wayne M Koch; Joseph A Califano; Richard A Gibbs; David Sidransky; Bert Vogelstein; Victor E Velculescu; Nickolas Papadopoulos; David A Wheeler; Kenneth W Kinzler; Jeffrey N Myers
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

7.  Presence of CD3-positive T-cells in oral premalignant leukoplakia indicates prevention of cancer transformation.

Authors:  Jenny Öhman; Rakeeba Mowjood; Lena Larsson; Anikó Kovacs; Bengt Magnusson; Göran Kjeller; Mats Jontell; Bengt Hasseus
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

Review 8.  Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.

Authors:  César Rivera; Ana Karina Oliveira; Rute Alves Pereira Costa; Tatiane De Rossi; Adriana Franco Paes Leme
Journal:  Oral Oncol       Date:  2017-07-12       Impact factor: 5.337

9.  The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.

Authors:  Kwame Osei-Sarfo; Xiao-Han Tang; Alison M Urvalek; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Carcinogenesis       Date:  2013-06-19       Impact factor: 4.944

10.  Understanding carcinogenesis for fighting oral cancer.

Authors:  Takuji Tanaka; Rikako Ishigamori
Journal:  J Oncol       Date:  2011-05-12       Impact factor: 4.375

View more
  2 in total

1.  A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.

Authors:  Melody T Tan; Jean G Wu; Juan Luis Callejas-Valera; Richard A Schwarz; Ann M Gillenwater; Rebecca R Richards-Kortum; Nadarajah Vigneswaran
Journal:  Int J Exp Pathol       Date:  2020-05-21       Impact factor: 1.925

Review 2.  Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.

Authors:  Roberto Rangel; Curtis R Pickering; Andrew G Sikora; Michael T Spiotto
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.